Irritable Bowel Syndrome with Diarrhea
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: The Role of Fiber in the Prevention and Treatment of Fecal Incontinence [NA]
Completed clinical trial studying the role of fiber in preventing and treating fecal incontinence and diarrhea-predominant irritable bowel s…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Curcumin, Vitamin D and Green Tea in IBS-D [NA]
A completed clinical trial evaluating curcumin, vitamin D, and green tea in irritable bowel syndrome, including IBS and IBS with diarrhea.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea [Phase 4]
Phase 4 clinical trial completion evaluating whether a hydrogen breath test can predict response to rifaximin in irritable bowel syndrome wi…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: The Effects of Carbohydrates in Irritable Bowel Syndrome [NA]
A completed clinical trial studied the effects of carbohydrate intake on symptoms in irritable bowel syndrome with diarrhea.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome [NA]
This is an ongoing clinical trial evaluating a nutraceutical composition for effects on signs and symptoms in adults with irritable bowel sy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1) [NA]
The clinical trial evaluating butyrate and palmitoylethanolamide for irritable bowel syndrome with diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D [NA]
Completed clinical trial evaluating the impact of dietary supplementation on intestinal barrier function in Irritable bowel syndrome with di…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Safety and Efficacy of a Probiotic Supplement in IBS-D [NA]
A clinical trial evaluating the safety and efficacy of a probiotic supplement for irritable bowel syndrome with diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: GI Permeability Change in Response to Aquamin® [Phase 2]
Phase 2 trial evaluating the effect of Aquamin on gastrointestinal permeability in Ulcerative Colitis patients, Irritable Bowel Syndrome wit…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: GOS to Reduce Symptom Severity in IBS [NA]
A completed clinical trial sponsored by Clasado evaluated galacto-oligosaccharide (GOS) for reducing symptom severity in irritable bowel syn…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Changkang Granule for diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy [NA]
Completed clinical trial evaluating Pan Capsule for symptomatic irritable bowel syndrome with diarrhea requiring colonoscopy.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of a probiotic formulation in adults with irritable bowel syndrome with diarrhe…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) [Phase 2]
Phase 2 trial of aldafermin (NGM282) for chronic diarrhea due to bile acid malabsorption has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea [Phase 4]
Phase 4 clinical trial comparing combination therapies for irritable bowel syndrome with diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Efficacy and Safety of Rifaximin With NAC in IBS-D [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating rifaximin with N-acetylcysteine for irritable bowel syndrome with diarrhea (IBS-D); results posted in…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) [Phase 4]
Phase 4 trial update evaluating Lactobacillus LB for Irritable Bowel Syndrome with Diarrhea (IBS-D).
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea [Phase 2]
A Phase 2 clinical trial assessing the efficacy and safety of DT01 tablets in patients with irritable bowel syndrome with diarrhea.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) [Phase 2]
This trial update reports termination of the Phase 2 study of olorlinab for irritable bowel syndrome, including IBS with constipation and IB…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome [Phase 4]
Phase 4 clinical trial update examining intestinal permeability and microbiota in Irritable Bowel Syndrome with Diarrhea.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 2]
Phase 2 trial comparing ORP-101 to placebo in adults with irritable bowel syndrome with diarrhea (IBS-D) has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Eluxadoline Bile Acid Malabsorption (BAM) Study [Phase 4]
Phase 4 trial update for eluxadoline in bile acid malabsorption related to irritable bowel syndrome with diarrhea has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating MD-7246 for abdominal pain in diarrhea-predominant irritable bowel syndrome (IBS-D) has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption [Phase 2]
Phase 2 trial evaluating colesevelam for diarrhea-predominant irritable bowel syndrome with bile acid malabsorption has completed with poste…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome [NA]
A completed clinical trial evaluating PX0612 for irritable bowel syndrome with diarrhea; results posted in 2019.